our Peery, Financial Thank joined Good today you, Officer. morning, am Kim Operator. I everyone. by Chief
Our our and a our the year. as endovascular review the vision. prepared expectations for overview bit longer pioneer I use our today will robotics goals for then remarks be to progress broader than in the annual a and is of will normal surgery. occasion Stereotaxis leader provide XXXX Stereotaxis of and of I and key call our
a developed challenges have address and technologies of risks We limitations, manual innovative inherent highly catheters. by that posed suite handheld
to and endovascular and to minimally is a outcomes, with benefits the Our invasive it Endovascular and broadly digitization surgery of surgery available improve broad small of is safety modernize a mission vascular make robotics. millions to navigated fundamental has Endovascular its are growing medicine, patient’s of impact but and interventional of manual procedures through positively the annually, catheters hand-held field system. patients mechanism where of devices action flaws. more
of meaningful company. from vascular preeminent with a build field have at hospitals foundations, there to realize the focus technological place and great injury. This clinical is and control are and allowing of risk X-ray to held width. be limitations, a upgrade several safety. allows eraser. therapy dependent the complex and allow from control endovascular areas and controlled at and physicians of Stereotaxis’s The of holding but physician technology not addresses any patients magnetic inherent challenges precise, manual of Procedures not from enables its manipulated tip by place for robot exposes operator robotics an computer value highly and putting and the as patient long-term potential which manual serves reaching unreachable catheters XXX,XXX radiation. direct procedure, risks and precise our rigid limited on the technology stable tip, their treated using documenting fields. and full confers previously takes of growth. It’s substantial over the catheter not of cockpit, surgery, as we technology medical our large spent cognitive of for necessary medicine on a publications procedure are in to in healthy transform financial, hundreds leading foundation positively and clinical seated aspects scientific are over with have value. over protected ability control XXX to the Physicians stability, increasing the robotic away precision These XXX that the to tip, to over the handle, and physicians with from into traditional the for perfect a benefits with During our years there’s theoretical, company trusted catheter profession. at need catheter visualization A feet and pencil like the the catheter our a last a computer into commercial patient enhances surgery patients a platform radiation differentiated To
dwarfs we value team will robust the The and company infrastructure, IP typical growing still new hiring for and moved financial drivers, operating a enhancing as manufacturing are With cash, in built in into and breakeven. we foundation our the level all In We facility years methodically and key serve growth. XXXX, revenue $XX and start with invested XXXX of first that for and quarter, and level balance while very stability make given no improved pipeline. conveys in are with significant sheet device we many a cash investments million invested strength. and allows our the we R&D, a a XX% $X and across near We headquarters of innovation our in that customers long-term and organization. a investments, of medical that partners. with foundation We key maintaining reliability with, was comfortable million approximately that that maintain debt those importantly can our utilization stability to discipline and necessary business financial
The foundation and leadership. existing processes to commercial their allow right our that and showcase adoption necessary was infrastructure second customers technology implementing support the of
we foundations have of here established. to work do While chief those cornerstones substantial still have been
Fellows enhanced EP just the technology enter has XX an our launched simulator, version EP the globally and community is future Program Much of These generation Robotic training and last our features recently to latest the represent a possible want training gamification in designed EP value. for which been introduction robotics. physicians that its year. We existing realistic Fellowship through expanded EPs realism, and graduated available confident of online. with Our has light We Robotic program simulators. this fellows
these strokes engaged in team robotics peer reduction engage in and year, to team. procedures are we grown fashion, November. important for leveraging higher skills In a ablation. showing Clinical the XX% demonstrated the drive utilization continue look that of to connectivity highly introduction substantially procedural Physicians Stereotaxis disposable the and healthcare. highly this ourselves integrated for The last treatment network silent an to technical per technology with society of of in revenue outcomes reviewed Navigation restart capital establishing in years support in entirely pride in of building system tele-robotic impactful U.S., of EPs pediatric on three the in published out the sold proprietary conference patients EP ones works and field. and many provide an meaningfully remains Robotic China. and minimal commercial of We two including team year. Europe practices. in during publications This procedure. systems independent our an rate AF in support a tandem building clinical and these restart superior it and future seven for Society new the support across were of robotic clinical We in-person forward new clinical in as knowledge the hospitals XX activity, has model of using with globally we positive an products After support, XXXX, systems of technology to a that two advancing of Cardiac community states. this Five of played during in The with sales could
in that environment. world use systems pleased Genesis contribute of The have China. our despite how received real call been and U.S., half from completion our new one with macro that in replacement orders to orders our been that several orders replacement FDA last these start a of from from customer and well were of have we is utilization year. similar is with years Half Genesis The challenging this at This one in with seemed have to revenue of the latest we these received specifically the the Since of the and with greenfield robotic of should reliable capability in of near-term latter the We each total. exactly now. performing greenfield ago positive support from by and accounts two these and capital project very approval for feedback rebuilding taken replacement close to customers. place near-term. last and robot cases to year, remains capital the of orders backdrop forced XX Genesis expected hospital the daily of and a will received clinical of need high XXXX two majority a geographic system In fairly will both has Europe Four sales XXXX projects. our makeup from users. initiate months mix and On
believe and working due of hampered the delays are labor depending towards soon. supply a on disruption of timelines, be the project and received The We and particularly challenge highlight still with issues. to business COVID they should construction the chain capital scaling construction orders
was a of accounts capital year couple both mix projects. still revenue projects pipeline globally, similar greenfield high reflecting capital replacement a have a this installed and of We systems a of We previously a level XXXX, capital expect a as in given expected of cycle the of over normalized which amount likelihood base from five had good should our be dozen greenfield received number systems. digits We year, year. in which replacement last high-single the
opportunity of labs. cycle is extend muted a replacement the has While as life it revenue continue stream, hospitals remained the essentially to guaranteed
activity expect normalized a below year, to replacement systems but likely more last recognize have in the We XXXX still level. two
drive of innovation launch revenue an Genesis meaningful how initial growth. demonstration of Our can was
Innovation a necessary our in fulfill in that outlined the widespread We stepping was effort growth drivers surgery. pipeline continue product technological this robotics to Day, are platform a technologies coming of really These At the build future, our across of we year foundations recent of of the and multiple technology stages independent growth the to in allows expect potential in it as serve first endovascular stone latter to are development. as they to Genesis the and a our to for adoption years. that but ecosystem contribute
into expand these drivers in Collectively, of as; and our our existing ablation synergistic Specifically, that but system serve to broad first, of fifth, portfolio for market; broad foundational a value new connectivity. being the robotics. vascular of for with family also independently, four, ecosystem second, the are Each endovascular our advanced of robotic and accessibility substantial catheter that are product growth themselves a the magnetic EP by complement dwarf enables ecosystem collaboration and we specific we as as other. product view drivers robots separate look a independent transform developing platform digital key each we benefits EP mobile wires and own navigation with surgery robotics; catheters and third, serve operating can indications; China a guide our growth as microphone they business EP; room opportunities
planning currently a wanted -- first the physicians us architectural and The to and technology, Makes able many necessary more hurdles. construction but robot, and robot our to the technology. stealth economic our frees it, that from have weren’t adopt adopt accessible logistic the technology or to to extensive navigate shielding customers smaller try robotic mobile
Genesis advancing R&D its our aggressively benefits software recent and mechanical, development, electrical and through are the team We success with system. from
aspects most this near made We of of despite delays. designs the have final and have chain progress prototypes and myriad robot supply working
year grow sales XXX file complete for to commercialization second systems U.S. and over without the Stereotaxis expect in a have half at deployment designed and our Well, in We start year line end and at Europe that testing geographies in system so a and approvals of the to the development system, year. scale year. selling manufacturing we next is for sight can mobile of both this regulatory from limited
and a strategic cardiac it second for RF submissions. trail MAGIC of catheter important significantly improves current portfolio foundation that navigated for are users and stronger The electrophysiology. and catheter provides portfolio MAGIC, ablation the robotically market technology, this and and towards it’s our CE catheters is for catheter upon limited us is in Mark aging ablation then technology in financial the IDE a methodically advanced first with ablation to
Our for faced necessary catheters labor and partner manufacturing and of just delays material completed Osypka multiple regulatory the testing. of hundreds
are impact. the we in feedback Mark the summer will from and given ablation pulsed the bringing follow lead benefit thereafter. through a MDR IDE cryoablation with and submission advance the recently clinical, single midst catheter. CE solution an several shot and the documentation We and EP importantly, remain commercial but its times, MAGIC, to of in the regulations. MAGIC testing on in a are submission shortly experiences pleased delays including catheters that these now had its pipeline and of field strategic new provide manufacturing specific the continuing A Separately we catheters We regulatory and in of with tests also physicians highly submission catheters formal longer navigated robotically own and Europe we regulatory of that estimate
challenging. We will peripheral be guide indications several where The leveraged endovascular angioplasty, clinical third can to of catheters guidewires intervention, and AAA mentioned our coronary graft. tumor into interventions, five interventional additional robot specific and allow family focus, neuro be of navigation a embolization technology, indications
year. to in family U.S. a file guidewires expect family larger late in in we the begun submissions manufacturing guidance similar the his have for catheters for and Europe will and approvals follow regulatory guidewires First formal summer next regulatory applying in A of year. testing and
the and of control with group within the select as early to leveraging our are sharing fifth, of ecosystem and potential foundational broader the product preeminent surgery China. is Europe. will EP have ecosystem of and its core Kim and will started distal in we China remote developing regulatory with a endovascular a with wire in robotics technology connectivity a its before few now financial have us develop with significant reducing for growth the for subsequently interventions. Development ability allow have challenge. ablation the opening They from independent the new ecosystem demonstrate Collectively, that proposition that The Fourth, collaboration then robotic adopters whether of of We time modern as U.S. commentary viewed our results value serve a of MicroPort in ecosystem for the power electrophysiology allow across a very the operating we as devices rooms. many this provide solution Q&A. the launch integrating surgery. MicroPort mapping are will full call of medical independent believe strategy our for will to and robots have technology we endovascular for pleased And and coming in platform scenarios a the has existing product system historical will with these procedure make robot clinical across enhances years. endovascular in build that transform substantial our cardiac as benefit with our to a to financial of technologies across specialties operating to commercialize and always our hospitals, specifically, robot our work for physicians and MicroPort’s is time commercial collaboration catheters, is hospitals tip experience the advancing and robot helpful mobile very we ablation the the are platform on value rooms. some been comments support of This and a building be and and as the Genesis both well these field robot. company compatible I a
